Khaitan Chemicals has announced its Q4 results for the fiscal year 2025-26, reporting an SSP capacity of 11.1 LMT. With a significant 10% market share, they operate six plants strategically located across five states.

Khaitan Chemicals faces a credit downgrade to IND BBB due to escalating costs and the Middle East conflict, leading to financial strain. The surge in sulphur prices and delayed subsidies have affected SSP's profitability, causing three production units to halt operations at KCFL over high raw material costs.

Khaitan Chemicals reported a significant 57% year-on-year increase in Q4 EBITDA, reaching ₹182M. The company's earnings margin also improved substantially, rising to 9.15%. This marks an impressive 1.9 percentage point jump compared to the previous year.

Khaitan Chemicals announced a final dividend of ₹0.05, pending approval at the upcoming Annual General Meeting. The stock closed at ₹62.71, with intraday highs reaching ₹68.14 and total turnover amounting to Rs. 90.9L.

Khaitan Chemicals will convene a board meeting on April 23, 2026, where they plan to adopt the audited financial reports, discuss Annual General Meeting-related matters, and close the trading window until the outcomes are disclosed.